Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | 1 | — | — | 1 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | 1 | — | — | 1 |
Drug common name | Gemigliptin |
INN | gemigliptin |
Description | Gemigliptin is an organonitrogen compound and an organooxygen compound. It is functionally related to a beta-amino acid. |
Classification | Small molecule |
Drug class | dipeptidyl aminopeptidase-IV inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | N[C@@H](CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1CC(F)(F)CCC1=O |
PDB | — |
CAS-ID | 911637-19-9 |
RxCUI | — |
ChEMBL ID | CHEMBL3707235 |
ChEBI ID | — |
PubChem CID | 11953153 |
DrugBank | DB12412 |
UNII ID | 5DHU18M5D6 (ChemIDplus, GSRS) |